Teva Canada Novamoxin recall in Canada: Out of specification results
In plain language
This recall involves Novamoxin Granules for Oral Suspension 125mg/5mL and 250mg/5mL sold in Canada. It's being recalled because of out of specification results for homogeneity. Stop using the product and follow the return/repair steps in the official notice.
What to do
- Stop using the product immediately.
- Check lot numbers if provided.
- Return or dispose of it as instructed.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Novamoxin Granules for Oral Suspension 125mg/5mL
Lot: 35438292B, 35438811A
Novamoxin Granules for Oral Suspension 250mg/5mL
Lot: 35439807A
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 35438292B, 35438811A, 35439807A
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves Novamoxin Granules for Oral Suspension 125mg/5mL and 250mg/5mL sold in Canada. It's being recalled because of out of specification results for homogeneity. Stop using the product and follow the return/repair steps in the official notice.
What should consumers do?
Stop using the product immediately. Check lot numbers if provided. Return or dispose of it as instructed.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on November 23, 2018.
Is the Novamoxin brand affected by this recall?
Yes, Novamoxin products are affected by this recall. This recall involves Novamoxin Granules for Oral Suspension 125mg/5mL and 250mg/5mL sold in Canada. It's being recalled because of out of specification results for homogeneity. Stop using the product and follow the return/repair steps in the official notice.